Running digitally for 2021, the 4th Neoantigen Summit Europe is industry-led meeting dedicated to the robust prediction, identification and .. Read more validation of neoantigens to develop potent tumorigenic immune responses. Join this exclusive community online to virtually network and learn from the leading experts in pharma, biotech and academia, to take part in stimulating discussions around shared and personalised neoantigens and how to realise the potential for neoantigens to create truly individualised cancer therapeutics. "The relevance of neoantigens in the clinical efficacy of immunotherapy is beyond doubt. However, several fundamental and practical questions remain unanswered and this meeting is an opportunity to discuss these issues with experts of the field.
- Share your Experience